1
|
Fiorentino TV, Prioletta A, Zuo P and
Folli F: Hyperglycemia-induced oxidative stress and its role in
diabetes mellitus related cardiovascular diseases. Curr Pharm Des.
19:5695–5703. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
Jeffcoate WJ and Harding KG: Diabetic foot
ulcers. Lancet. 361:1545–1551. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chiaramonte R, Basile A, Tassi E,
Calzavara E, Cecchinato V, Rossi V, Biondi A and Comi P: A wide
role for NOTCH1 signaling in acute leukemia. Cancer Lett.
219:113–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
4
|
Hellström M, Phng LK, Hofmann JJ, Wallgard
E, Coultas L, Lindblom P, Alva J, Nilsson AK, Karlsson L, Gaiano N,
et al: Dll4 signalling through Notch1 regulates formation of tip
cells during angiogenesis. Nature. 445:776–780. 2007. View Article : Google Scholar : PubMed/NCBI
|
5
|
Williams CK, Li JL, Murga M, Harris AL and
Tosato G: Up-regulation of the Notch ligand Delta-like 4 inhibits
VEGF-induced endothelial cell function. Blood. 107:931–939. 2006.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Kopan R and Ilagan MX: The canonical Notch
signaling pathway: Unfolding the activation mechanism. Cell.
137:216–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
7
|
Ishiko E, Matsumura I, Ezoe S, Gale K,
Ishiko J, Satoh Y, Tanaka H, Shibayama H, Mizuki M, Era T, et al:
Notch signals inhibit the development of erythroid/megakaryocytic
cells by suppressing GATA-1 activity through the induction of HES1.
J Biol Chem. 280:4929–4939. 2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Garg V, Muth AN, Ransom JF, Schluterman
MK, Barnes R, King IN, Grossfeld PD and Srivastava D: Mutations in
NOTCH1 cause aortic valve disease. Nature. 437:270–274. 2005.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Iso T, Kedes L and Hamamori Y: HES and
HERP families: Multiple effectors of the Notch signaling pathway. J
Cell Physiol. 194:237–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Liao WR, Hsieh RH, Hsu KW, Wu MZ, Tseng
MJ, Mai RT, Wu Lee YH and Yeh TS: The CBF1-independent Notch1
signal pathway activates human c-myc expression partially via
transcription factor YY1. Carcinogenesis. 28:1867–1876. 2007.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Jaiswal MK, Agrawal V, Pamarthy S, Katara
GK, Kulshrestha A, Gilman-Sachs A, Beaman KD and Hirsch E: Notch
signaling in inflammation-induced preterm labor. Sci Rep.
5:152212015. View Article : Google Scholar : PubMed/NCBI
|
12
|
Xie F, Cai W, Liu Y, Li Y, Du B, Feng L
and Qiu L: Vaccarin attenuates the human EA.hy926 endothelial cell
oxidative stress injury through inhibition of Notch signaling. Int
J Mol Med. 35:135–142. 2015.PubMed/NCBI
|
13
|
Xi G, Shen X, Wai C, Vilas CK and Clemmons
DR: Hyperglycemia stimulates p62/PKCζ interaction, which mediates
NF-κB activation, increased Nox4 expression, and inflammatory
cytokine activation in vascular smooth muscle. FASEB J.
29:4772–4782. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fang Q, Wang J, Wang L, Zhang Y, Yin H, Li
Y, Tong C, Liang G and Zheng C: Attenuation of inflammatory
response by a novel chalcone protects kidney and heart from
hyperglycemia-induced injuries in type 1 diabetic mice. Toxicol
Appl Pharmacol. 288:179–191. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Ferrer-Lorente R, Bejar MT and Badimon L:
Notch signaling pathway activation in normal and hyperglycemic rats
differs in the stem cells of visceral and subcutaneous adipose
tissue. Stem Cells Dev. 23:3034–3048. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhou Y, Gu P, Shi W, Li J, Hao Q, Cao X,
Lu Q and Zeng Y: MicroRNA-29a induces insulin resistance by
targeting PPARδ in skeletal muscle cells. Int J Mol Med.
37:931–938. 2016.PubMed/NCBI
|
17
|
Silambarasan M, Tan JR, Karolina DS,
Armugam A, Kaur C and Jeyaseelan K: MicroRNAs in hyperglycemia
induced endothelial cell dysfunction. Int J Mol Sci. 17:5182016.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Ocłoń E, Latacz A, Zubel-Łojek J and
Pierzchała-Koziec K: Hyperglycemia-induced changes in miRNA
expression patterns in epicardial adipose tissue of piglets. J
Endocrinol. 229:259–266. 2016. View Article : Google Scholar : PubMed/NCBI
|
19
|
Magenta A, Cencioni C, Fasanaro P,
Zaccagnini G, Greco S, Sarra-Ferraris G, Antonini A, Martelli F and
Capogrossi MC: miR-200c is upregulated by oxidative stress and
induces endothelial cell apoptosis and senescence via ZEB1
inhibition. Cell Death Differ. 18:1628–1639. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Luo Z, Wen G, Wang G, Pu X, Ye S, Xu Q,
Wang W and Xiao Q: MicroRNA-200C and −150 play an important role in
endothelial cell differentiation and vasculogenesis by targeting
transcription repressor ZEB1. Stem Cells. 31:1749–1762. 2013.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Song C, Liu LZ, Pei XQ, Liu X, Yang L, Ye
F and Xie X, Chen J, Tang H and Xie X: miR-200c inhibits breast
cancer proliferation by targeting KRAS. Oncotarget. 6:34968–34978.
2015.PubMed/NCBI
|
22
|
Kumar K, Chow CR, Ebine K, Arslan AD, Kwok
B, Bentrem DJ, Eckerdt FD, Platanias LC and Munshi HG: Differential
Regulation of ZEB1 and EMT by MAPK-interacting protein kinases
(MNKs) and eIF4E in pancreatic cancer. Mol Cancer Res. 14:216–227.
2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Guilini C, Urayama K, Turkeri G, Dedeoglu
DB, Kurose H, Messaddeq N and Nebigil CG: Divergent roles of
prokineticin receptors in the endothelial cells: Angiogenesis and
fenestration. Am J Physiol Heart Circ Physiol. 298:H844–H852. 2010.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Liu S, Ma X, Ai Q, Huang Q, Shi T, Zhu M,
Wang B and Zhang X: NOTCH1 functions as an oncogene by regulating
the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma. Urol
Oncol. 31:938–948. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Zhou Y, Li JS, Zhang X, Wu YJ, Huang K and
Zheng L: Ursolic acid inhibits early lesions of diabetic
nephropathy. Int J Mol Med. 26:565–570. 2010.PubMed/NCBI
|